Immix Biopharma, Inc. IMMX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$29.4M-35.5% | -$21.7M-39.1% | -$15.6M-89.5% | -$8.23M+66.2% | ||
| $245.75K+646% | $32.94K+502% | $5.47K+156% | $2.14K-13.5% | ||
| $2.44M-19.2% | $3.02M+17.7% | $2.57M+311% | $624.07K+185% | ||
| -$23.93M-64.0% | -$14.6M-28.3% | -$11.37M-53.5% | -$7.41M-366% | ||
| $732.93K-37.8% | $1.18M— | —— | —— | ||
| -$7.21M-513% | -$1.18M— | —— | —— | ||
| —— | —— | $15.46M— | —— | ||
| $76.25M— | —— | —— | -$4.21M-124% | ||
| -$24.66M-56.4% | -$15.77M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Immix Biopharma, Inc. generate?
- Immix Biopharma, Inc. (IMMX) generated -$32.1M in operating cash flow over the trailing twelve months.
- What is Immix Biopharma, Inc.'s free cash flow?
- After $697.7K of capital expenditures, Immix Biopharma, Inc.'s free cash flow was -$32.8M over the trailing twelve months, down 144.6% year over year.
- Where does Immix Biopharma, Inc.'s cash flow data come from?
- Every line is extracted from Immix Biopharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.